NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
$1.37−0.14 (-9.27%)
Close on Nov 18, 2026Market cap $2.52MP/E –Yield –
NeuroSense Therapeutics total assets
Total assets on the balance sheet at the end of each period.
NeuroSense Therapeutics's total assets was $896.00K at Jun 30, 2026. For fiscal 2025 it was $1.03M, down 77.5% from the year before. The highest annual figure on record is $11.43M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03M | -77.5% |
| FY2024 | Dec 31, 2024 | $4.58M | +43.6% |
| FY2023 | Dec 31, 2023 | $3.19M | -58.7% |
| FY2022 | Dec 31, 2022 | $7.72M | -32.5% |
| FY2021 | Dec 31, 2021 | $11.43M | +1367.4% |
| FY2020 | Dec 31, 2020 | $779.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $896.00K | -51.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.03M | -67.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.68M | -78.6% |
| Q4 FY2024 | Dec 31, 2024 | $4.58M | -40.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.84M | -83.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.19M | -72.1% |
| Q2 FY2023 | Jun 30, 2023 | $7.87M | +910.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.72M | – |
| Q2 FY2022 | Jun 30, 2022 | $11.45M | – |
| Q4 FY2021 | Dec 31, 2021 | $11.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $779.00K | – |
See a number that looks wrong?